Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Sumitomo Pharma Co., Ltd.
ISIN JP3495000006
|WKN 858257
Market cap (in EUR)
4,988 m
Country
Japan
Sector
Healthcare
Dividend yield
1.68%
Overview
Description
Sumitomo Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment manufactures and sells generic and prescription drugs in Japan, North America, China, and other overseas countries. The Other Business segment division includes food ingredients, additives, chemical products, veterinary drugs, and diagnostic reagents. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan.
Healthcare Biopharmaceuticals Other Biopharmaceuticals Japan
Financials
Key metrics
| Market capitalisation, EUR | 4,988 m |
| EPS, EUR | 1.64 |
| P/B ratio | 3.2 |
| P/E ratio | 8.4 |
| Dividend yield | 1.68% |
Income statement (2024)
| Revenue, EUR | 2,440 m |
| Net income, EUR | 145 m |
| Profit margin | 5.93% |
What ETF is Sumitomo Pharma Co., Ltd. in?
There are 22 ETFs which contain Sumitomo Pharma Co., Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Sumitomo Pharma Co., Ltd. is the iShares MSCI Japan Small Cap UCITS ETF (Dist).
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.